Closing the Gaps in NSCLC

Closing the Gaps in NSCLC

By ReachMDMedicine
Download on the App Store

Closing the Gaps in NSCLC episodes

  • Facing False Positives in CT-Based NSCLC Screenings
    Host: Matt Birnholz, MD
    Guest: Everett E. Vokes, MD

    To address some of the difficulties surrounding CT-based NSCLC screenings, Dr. Everett Vokes provides guidance to thwart false positives.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Clinical Pearls for Challenging Cases of Advanced NSCLC
    Host: Matt Birnholz, MD
    Guest: Everett E. Vokes, MD

    With no one patient being the same, there’s a lot to consider when developing a treatment plan for advanced non-small cell lung cancer, and complex cases, such as elderly patients, can bring considerable uncertainty. Dr. Everett Vokes dives into the strategies he uses to guide his decisions when he’s faced with a challenging case.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • A Practical Perspective on Aggressive Disease Management in NSCLC
    Host: Matt Birnholz, MD
    Guest: Everett E. Vokes, MD

    Flipping the term “aggressive” on its head is Dr. Everett Vokes from the University of Chicago. Dr. Vokes unveils the term “intensive therapy” to describe his approach to aggressive NSCLC management and provides us with his rationale behind implementing this approach into practice.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • The Expanding Value of Biomarkers in NSCLC Treatment
    Host: Shira Johnson, MD
    Guest: Ross Camidge, MD, PhD

    The treatment landscape for non-small cell lung cancer is continuing to expand, and playing a major role in clinical decision-making are biomarkers. Dr. Ross Camidge reveals the importance of these molecular signatures with Dr. Shira Johnson and how he applies them in practice.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • NSCLC: An Aggressive Approach for Personalized Therapy
    Guest: Ross Camidge, MD, PhD

    Dr. Ross Camidge from the University of Colorado discusses the concepts to consider and his own personal rationales behind implementing aggressive disease management for patients with NSCLC.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • A Memorable Lesson Learned from a Patient with NSCLC
    Host: Matt Birnholz, MD
    Guest: Ross Camidge, MD, PhD

    After repeated chemotherapy sessions, many patients feel the repercussions and pain. But beyond the pain is the loss of quality of life. Dr. Ross Camidge, Director of Thoracic Oncology at the University of Colorado Cancer Center, navigates us through one unforgettable case of a patient with NSCLC, which holds an unexpected lesson for all physicians

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Doctor-Patient Relationship Remedies in NSCLC
    Host: Shira Johnson, MD
    Guest: Ross Camidge, MD, PhD

    Building a strong physician-patient relationship is in many ways a complex process. But since it’s the foundation to exceptional care in NSCLC, this trust and confidence could influence your patient’s decision to take or skip the next dose. Dr. Ross Camidge from the University of Colorado discusses the strategies she implements in her practice to optimize partnerships with patients.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Keys to Accurate Diagnostic Staging for NSCLC
    Guest: Edward S. Kim, MD

    Obtaining a tissue biopsy has always been the standard for reaching both early and late-stage non-small cell lung cancer (NSCLC) diagnoses, but that’s no longer the case for all stages. See for yourself how the paradigm has changed with Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Perspectives on How KEYNOTE-189 Is Changing NSCLC Care Paradigms
    Guest: Edward S. Kim, MD

    For those non-small cell lung cancer (NSCLC) patients without driver mutations or PD-L expressions, the new care paradigm brought on by KEYNOTE-189 has shown to improve these patients’ progression-free survival rates. Here to break down this clinical trial’s unprecedented findings is Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • An NSCLC Expert’s Take on Aggressive Disease Management
    Guest: Edward S. Kim, MD

    What’s the best course of action for those patients with non-small cell lung cancer (NSCLC) that’s rapidly growing? Join Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute, as he reviews some of the methods that aim to achieve the best response rate in these patients.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min

About Closing the Gaps in NSCLC

From the publisher's feed

Not only is lung cancer the leading cause of cancer deaths among females and males, but it’s also the most common type of cancer. Despite its high prevalence and mortality rates, communicative care between non-small cell lung cancer (NSCLC) patients and their providers is still unfortunately lacking.